Aptamer-target interaction descriptor
Aptamer-target interaction information
Interaction ID: 383
Aptamer sequence: CUUCGGGAUUUGAGGGUAGAAUGGGACUA
Target unique ID: P27958
Aptamer ID Aptamer descriptor Target chemistry Target name Affinity Binding Conditions/Buffer PubMed ID
Apta_377 G9-Ⅰ Protein POLG_HCV77 11.6 nM 50 mM Tris/HCl (pH 7.8), 30 mM NaCl, 5 mM CaCl2 and 10 mM dithiothreitol 10848986
Structure information of aptamer
Aptamer Sequence: CUUCGGGAUUUGAGGGUAGAAUGGGACUA
The optimal secondary structure in dot-bracket notation: (((((.....)))))..............
The centroid secondary structure in dot-bracket notation: (((((.....)))))..............
The MFE structure
The Centroid structure
The mountain plot representation
Aptamer information
Type Detail Type Detail
Aptamer ID Apta_377 Description G9-Ⅰ
Aptamer chemistry RNA Length 29 nt
GC content 48.3% Molecular weight 9,404.61 Da
Molarity of 1 μg/μl solution 106.33 μM Number of G-quadruplexes No QGRS found
G-Score N/A Function Targeted binding
Sequence CUUCGGGAUUUGAGGGUAGAAUGGGACUA
Applications Selected aptamers have potential as anti-HCV compounds
Target information
Type Detail Type Detail
Uniprot ID P27958 Protein name Genome polyprotein [Cleaved into: Core protein precursor (Capsid protein C) (p23); Mature core protein (p21); Envelope glycoprotein E1 (gp32) (gp35); Envelope glycoprotein E2 (NS1) (gp68) (gp70); Viroporin p7; Protease NS2 (p23) (EC 3.4.22.-) (Non-structural protein 2) (NS2); Serine protease/helicase NS3 (EC 3.4.21.98) (EC 3.6.1.15) (EC 3.6.4.13) (Hepacivirin) (NS3 helicase) (NS3 protease) (NS3P) (Viroporin p70); Non-structural protein 4A (NS4A) (p8); Non-structural protein 4B (NS4B) (p27); Non-structural protein 5A (NS5A) (p56/58); RNA-directed RNA polymerase (EC 2.7.7.48) (NS5B) (p68)]
Gene name(s) N/A Organism Genome polyprotein [Cleaved into: Core protein precursor (Capsid protein C) (p23); Mature core protein (p21); Envelope glycoprotein E1 (gp32) (gp35); Envelope glycoprotein E2 (NS1) (gp68) (gp70); Viroporin p7; Protease NS2 (p23) (EC 3.4.22.-) (Non-structural protein 2) (NS2); Serine protease/helicase NS3 (EC 3.4.21.98) (EC 3.6.1.15) (EC 3.6.4.13) (Hepacivirin) (NS3 helicase) (NS3 protease) (NS3P) (Viroporin p70); Non-structural protein 4A (NS4A) (p8); Non-structural protein 4B (NS4B) (p27); Non-structural protein 5A (NS5A) (p56/58); RNA-directed RNA polymerase (EC 2.7.7.48) (NS5B) (p68)]
Status reviewed in uniprot database Length 3011
Mass 327,146 Activity regulation Inhibited by the antiviral drug hexamethylene amiloride (By similarity)
Involvement in disease N/A Catalytic activity Reaction=Hydrolysis of four peptide bonds in the viral precursor polyprotein, commonly with Asp or Glu in the P6 position, Cys or Thr in P1 and Ser or Ala in P1
PDB ID(s)
1A1R;1A1V;1CWX;1HEI;1JR6;1N1L;1ONB;1R7C;1R7D;1R7E;1R7F;1R7G;1RGQ;2A4R;2F9V;2HD0;2JXF;2KDR;2N1P;2O8M;2OBO;2OBQ;2OC0;2OC1;2OC7;2OC8;2OIN;2P59;2QV1;2XI2;2XI3;2XNI;3RC4;3RC5;4CL1;4JZN;4JZO;4MWF;4N0Y;4Q0X;4XVJ;4Z0X;5EOC;5ERW;5FGB;5FGC;5JZI;5YXN;5YXU;6BQJ;6BQK;6BZU;6BZV;6BZW;6BZY;6UYD;6WO5;6WOQ;
Function Packages viral RNA to form a viral nucleocapsid, and promotes virion budding (Probable).
Activity data
Interaction ID 383
Target type Protein
Target unique ID P27958
Activity 11.6 nM
Binding Conditions/Buffer

50 mM Tris/HCl (pH 7.8), 30 mM NaCl, 5 mM CaCl2 and 10 mM dithiothreitol

Assay

Binding curves of selected RNA aptamers and DNS3. Data points were obtained by filter binding assay (50 mL reaction) as described in Materials and methods (G9-I, circle; G9-II, cross; and G9-III, square). The concentration of labeled aptamers was 5 nm

PubMed ID 10848986
Similar aptamers
Aptamer ID Aptamer chemistry Sequence Similarity
Apta_93 RNA CUCCGCUAUCUAACGUAUGAUAGAAUGGAUGACUA 65.71%
Apta_924 RNA GCCUUUUCGGGAUACGCGGAGGGUGGGCAA 56.67%
Apta_925 RNA GCUCGGCCAGGUCGCGGGUGGAUGUGAGGG 53.33%
Apta_237 RNA UUCAACGCUGUGAAGGGCUUAUACGAGCGGAUUACCC 51.35%
Apta_212 RNA AGGAAGGCUUUAGGUCUGAGAUCUCGGAAU 50.00%
Apta_218 RNA AGCCGCGAGGGGAGGGAUAGGGUAGGGCGCGGCU 50.00%
Apta_379 RNA UACGACACGAUUGGGACGUGUCUAUGGGAC 50.00%
Apta_633 RNA GGCAUCGGAAAGUGGGUUGAUGUAAGUAACAGGCGAUGCC 50.00%
Apta_381 RNA AUUCUGUUGGCGAACUGUACGCAAGUACUGGAUGACAGCCUAUCUAU 48.94%
Apta_51 RNA GCCUUAGUAACGUGCUUUGAUGUCGAUUCGACAGGAGGC 48.72%
Apta_95 RNA CCGCGACAGUCGUAAGUUUUGACUGACUGAACGUU 48.57%
Apta_230 RNA GGGAGGACGAUGCGGGCGUGAAUGGUGUUGUGAGG 48.57%
Apta_231 RNA GGGAGGACGAUGCGGGUGUGGGGCG 48.28%
Apta_373 RNA CCAUACGGGAGAGAAACU 48.28%
Apta_136 RNA CGUGUCGUCCUGGUACGAUUUGGUAUAUAACCGUGGCUUUUCGACA 47.83%
Apta_242 RNA GCUUCCAGGAAGAGAAGUGUCAUGUGAUCAGUCCUGGUGGGUGG 47.73%
Apta_402 RNA GCCUGUAAGGUGGUCGGUGUGGCGAGUGUGUUAGGAGAGAUUGC 47.73%
Apta_606 RNA CGGUUGGAUGGGUGUUGGUGGUUUGUUGAGUCCAGGCGGC 47.50%
Apta_98 RNA CGAUGCGGUCUCAUGCGUCGAGUGUGAGUUUACCUUCG 47.37%
Apta_647 RNA GGAUCCCGACUGGCGAGAGCCAGGUAACGAAUGGAUCC 47.37%